Hydrolyzed Collagen Supplement Firm Agrees To Order Barring Claims To Grow Bone, Cartilage
Executive Summary
Claims of bone and cartilage growth, along with relief of joint pain, shot down by FTC. But company says claims “are adequately substantiated by existing studies and scientific literature.”
You may also be interested in...
US FTC Pulling Various Levers To Impose Monetary Relief On False Ad Defendants
The Federal Trade Commission is leveraging other statutory authorities under the FTC Act and working with state regulators to garner monetary relief for consumers in the year since a Supreme Court decision shut down the commission’s longtime pathway for doing so under Sec. 13(b). FTC Bureau of Consumer Protection director Samuel Levine provided an update – and a warning to industry – at the NAD 2022 conference.
FTC Will Ask Congress To Sharpen Monetary Relief Authority Dulled By Supreme Court Ruling
Justice Breyer suggests FTC ask Congress to strengthen its enforcement rules. It is “free to ask Congress to grant it further remedial authority,” according to court opinion stating a rule the FTC has wielded for forty years to impose financial penalties doesn’t grant it authority to obtain equitable monetary relief.
HBW Market News: FTC Targets Bone Health Claims, Puration Offers To Buy Hemp4mula, More
FTC settled with one firm and is pursuing litigation against another after alleging claimed supplements could grow bone and cartilage; CBD beverage firm Puration offers to acquire Hemp4mula; and Huron Capital’s Ronnoco Beverage business acquires Trident Beverage.